Publication Information

{'id': 'https://openalex.org/W3083550746', 'doi': 'https://doi.org/10.1124/molpharm.120.000103', 'title': 'Antiepileptic Drug–Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator–Activated Receptor<i>α</i>and Peroxisome Proliferator–Activated Receptor<i>γ</i>Coactivator 1<i>α</i>–Dependent Gene Expression to Increase Blood Triglyceride Levels', 'display_name': 'Antiepileptic Drug–Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator–Activated Receptor<i>α</i>and Peroxisome Proliferator–Activated Receptor<i>γ</i>Coactivator 1<i>α</i>–Dependent Gene Expression to Increase Blood Triglyceride Levels', 'publication_year': 2020, 'publication_date': '2020-09-05', 'ids': {'openalex': 'https://openalex.org/W3083550746', 'doi': 'https://doi.org/10.1124/molpharm.120.000103', 'mag': '3083550746', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/32892155'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1124/molpharm.120.000103', 'pdf_url': 'https://molpharm.aspetjournals.org/content/molpharm/98/5/634.full.pdf', 'source': {'id': 'https://openalex.org/S62949411', 'display_name': 'Molecular Pharmacology', 'issn_l': '0026-895X', 'issn': ['0026-895X', '1521-0111'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316283', 'host_organization_name': 'American Society for Pharmacology and Experimental Therapeutics', 'host_organization_lineage': ['https://openalex.org/P4310316283'], 'host_organization_lineage_names': ['American Society for Pharmacology and Experimental Therapeutics'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://molpharm.aspetjournals.org/content/molpharm/98/5/634.full.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5090124420', 'display_name': 'Ryota Shizu', 'orcid': 'https://orcid.org/0000-0002-0465-5077'}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Ryota Shizu', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101535558', 'display_name': 'Yuta Otsuka', 'orcid': 'https://orcid.org/0000-0003-2482-2802'}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yuta Otsuka', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074332146', 'display_name': 'Kanako Ezaki', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kanako Ezaki', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112599908', 'display_name': 'Chizuru Ishii', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Chizuru Ishii', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5114045886', 'display_name': 'Shingo Arakawa', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shingo Arakawa', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031075942', 'display_name': 'Yuto Amaike', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yuto Amaike', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045973331', 'display_name': 'Taiki Abe', 'orcid': 'https://orcid.org/0000-0001-6580-3734'}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Taiki Abe', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109373624', 'display_name': 'Takuomi Hosaka', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Takuomi Hosaka', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102021442', 'display_name': 'Takamitsu Sasaki', 'orcid': 'https://orcid.org/0000-0002-2248-5382'}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Takamitsu Sasaki', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052444820', 'display_name': 'Yuichiro Kanno', 'orcid': 'https://orcid.org/0000-0002-7551-6410'}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yuichiro Kanno', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103242557', 'display_name': 'Masaaki Miyata', 'orcid': 'https://orcid.org/0000-0002-7727-3432'}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masaaki Miyata', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069722397', 'display_name': 'Yasushi Yamazoe', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yasushi Yamazoe', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5012944884', 'display_name': 'Kouichi Yoshinari', 'orcid': 'https://orcid.org/0000-0002-2027-2017'}, 'institutions': [{'id': 'https://openalex.org/I4210104626', 'display_name': 'Daiichi-Sankyo (Japan)', 'ror': 'https://ror.org/027y26122', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210104626']}, {'id': 'https://openalex.org/I201537933', 'display_name': 'Tohoku University', 'ror': 'https://ror.org/01dq60k83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I201537933']}, {'id': 'https://openalex.org/I150240954', 'display_name': 'University of Shizuoka', 'ror': 'https://ror.org/04rvw0k47', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I150240954']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kouichi Yoshinari', 'raw_affiliation_strings': ['Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)'], 'affiliations': [{'raw_affiliation_string': 'Pharmacovigilance Department, Clinical Safety and Pharmacovigilance Division, Daiichi Sankyo Co., Ltd., Chuo-ku, Tokyo, Japan (S.A.)', 'institution_ids': ['https://openalex.org/I4210104626']}, {'raw_affiliation_string': 'Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan (Y.O., C.I., T.A., M.M., Y.Y., K.Y.)', 'institution_ids': ['https://openalex.org/I201537933']}, {'raw_affiliation_string': 'Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka,Suruga-ku, Shizuoka, Japan (R.S., K.E., Y.A., T.A., T.H., T.S., Y.K., K.Y.)', 'institution_ids': ['https://openalex.org/I150240954']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.551, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 8, 'citation_normalized_percentile': {'value': 0.690713, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 84, 'max': 85}, 'biblio': {'volume': '98', 'issue': '5', 'first_page': '634', 'last_page': '647'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11072', 'display_name': 'Peroxisome Proliferator-Activated Receptors', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11072', 'display_name': 'Peroxisome Proliferator-Activated Receptors', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11339', 'display_name': 'Metabolism, Diabetes, and Cancer', 'score': 0.9922, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11027', 'display_name': 'Metabolism and Genetic Disorders', 'score': 0.9919, 'subfield': {'id': 'https://openalex.org/subfields/1308', 'display_name': 'Clinical Biochemistry'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/constitutive-androstane-receptor', 'display_name': 'Constitutive androstane receptor', 'score': 0.842204}], 'concepts': [{'id': 'https://openalex.org/C77445288', 'wikidata': 'https://www.wikidata.org/wiki/Q637488', 'display_name': 'Coactivator', 'level': 4, 'score': 0.86217}, {'id': 'https://openalex.org/C193264327', 'wikidata': 'https://www.wikidata.org/wiki/Q14905078', 'display_name': 'Constitutive androstane receptor', 'level': 5, 'score': 0.842204}, {'id': 'https://openalex.org/C187345961', 'wikidata': 'https://www.wikidata.org/wiki/Q419629', 'display_name': 'Peroxisome proliferator-activated receptor', 'level': 3, 'score': 0.79151}, {'id': 'https://openalex.org/C63932345', 'wikidata': 'https://www.wikidata.org/wiki/Q422500', 'display_name': 'Nuclear receptor', 'level': 4, 'score': 0.6376711}, {'id': 'https://openalex.org/C188413054', 'wikidata': 'https://www.wikidata.org/wiki/Q18030677', 'display_name': 'Peroxisome proliferator-activated receptor alpha', 'level': 5, 'score': 0.5670488}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4876236}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.477114}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.46159148}, {'id': 'https://openalex.org/C4733338', 'wikidata': 'https://www.wikidata.org/wiki/Q2792936', 'display_name': 'Lipid metabolism', 'level': 2, 'score': 0.41943732}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.3903315}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.36881608}, {'id': 'https://openalex.org/C86339819', 'wikidata': 'https://www.wikidata.org/wiki/Q407384', 'display_name': 'Transcription factor', 'level': 3, 'score': 0.3502419}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.18733105}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.099345565}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0816645}], 'mesh': [{'descriptor_ui': 'D000927', 'descriptor_name': 'Anticonvulsants', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D047493', 'descriptor_name': 'PPAR alpha', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D047495', 'descriptor_name': 'PPAR gamma', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D000071248', 'descriptor_name': 'Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D018160', 'descriptor_name': 'Receptors, Cytoplasmic and Nuclear', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D014280', 'descriptor_name': 'Triglycerides', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000927', 'descriptor_name': 'Anticonvulsants', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000090702', 'descriptor_name': 'Constitutive Androstane Receptor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004790', 'descriptor_name': 'Enzyme Induction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004790', 'descriptor_name': 'Enzyme Induction', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D011345', 'descriptor_name': 'Fenofibrate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011345', 'descriptor_name': 'Fenofibrate', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D056945', 'descriptor_name': 'Hep G2 Cells', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D022781', 'descriptor_name': 'Hepatocytes', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D022781', 'descriptor_name': 'Hepatocytes', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D022781', 'descriptor_name': 'Hepatocytes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D050356', 'descriptor_name': 'Lipid Metabolism', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D050356', 'descriptor_name': 'Lipid Metabolism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008099', 'descriptor_name': 'Liver', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008099', 'descriptor_name': 'Liver', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D008099', 'descriptor_name': 'Liver', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008810', 'descriptor_name': 'Mice, Inbred C57BL', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047493', 'descriptor_name': 'PPAR alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047495', 'descriptor_name': 'PPAR gamma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000071248', 'descriptor_name': 'Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010634', 'descriptor_name': 'Phenobarbital', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D010634', 'descriptor_name': 'Phenobarbital', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018160', 'descriptor_name': 'Receptors, Cytoplasmic and Nuclear', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014157', 'descriptor_name': 'Transcription Factors', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D014157', 'descriptor_name': 'Transcription Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015533', 'descriptor_name': 'Transcriptional Activation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D015533', 'descriptor_name': 'Transcriptional Activation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014280', 'descriptor_name': 'Triglycerides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1124/molpharm.120.000103', 'pdf_url': 'https://molpharm.aspetjournals.org/content/molpharm/98/5/634.full.pdf', 'source': {'id': 'https://openalex.org/S62949411', 'display_name': 'Molecular Pharmacology', 'issn_l': '0026-895X', 'issn': ['0026-895X', '1521-0111'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316283', 'host_organization_name': 'American Society for Pharmacology and Experimental Therapeutics', 'host_organization_lineage': ['https://openalex.org/P4310316283'], 'host_organization_lineage_names': ['American Society for Pharmacology and Experimental Therapeutics'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/32892155', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1124/molpharm.120.000103', 'pdf_url': 'https://molpharm.aspetjournals.org/content/molpharm/98/5/634.full.pdf', 'source': {'id': 'https://openalex.org/S62949411', 'display_name': 'Molecular Pharmacology', 'issn_l': '0026-895X', 'issn': ['0026-895X', '1521-0111'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316283', 'host_organization_name': 'American Society for Pharmacology and Experimental Therapeutics', 'host_organization_lineage': ['https://openalex.org/P4310316283'], 'host_organization_lineage_names': ['American Society for Pharmacology and Experimental Therapeutics'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.75, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 52, 'referenced_works': ['https://openalex.org/W1485938486', 'https://openalex.org/W1523158326', 'https://openalex.org/W1526348057', 'https://openalex.org/W1528208931', 'https://openalex.org/W1961815330', 'https://openalex.org/W1964036912', 'https://openalex.org/W1967211333', 'https://openalex.org/W1973238763', 'https://openalex.org/W1974744093', 'https://openalex.org/W1977666051', 'https://openalex.org/W1992127373', 'https://openalex.org/W1994113968', 'https://openalex.org/W1996334614', 'https://openalex.org/W1999766693', 'https://openalex.org/W2008825225', 'https://openalex.org/W2009838390', 'https://openalex.org/W2010904416', 'https://openalex.org/W2014550551', 'https://openalex.org/W2016366885', 'https://openalex.org/W2040669411', 'https://openalex.org/W2040853595', 'https://openalex.org/W2047646295', 'https://openalex.org/W2060802146', 'https://openalex.org/W2061879307', 'https://openalex.org/W2063125253', 'https://openalex.org/W2071355536', 'https://openalex.org/W2073950955', 'https://openalex.org/W2076750433', 'https://openalex.org/W2083802972', 'https://openalex.org/W2084720330', 'https://openalex.org/W2093302148', 'https://openalex.org/W2103116278', 'https://openalex.org/W2113328569', 'https://openalex.org/W2118637985', 'https://openalex.org/W2127141044', 'https://openalex.org/W2134778167', 'https://openalex.org/W2138506509', 'https://openalex.org/W2141789735', 'https://openalex.org/W2147956448', 'https://openalex.org/W2150884892', 'https://openalex.org/W2170932182', 'https://openalex.org/W2171277628', 'https://openalex.org/W2527003745', 'https://openalex.org/W2598710314', 'https://openalex.org/W2604028246', 'https://openalex.org/W2770535637', 'https://openalex.org/W2794186388', 'https://openalex.org/W2807576427', 'https://openalex.org/W2883371150', 'https://openalex.org/W2940003391', 'https://openalex.org/W3011576729', 'https://openalex.org/W3107435168'], 'related_works': ['https://openalex.org/W4301380263', 'https://openalex.org/W3083550746', 'https://openalex.org/W2888397866', 'https://openalex.org/W2605340400', 'https://openalex.org/W2402208918', 'https://openalex.org/W2346431707', 'https://openalex.org/W2316296538', 'https://openalex.org/W2073807083', 'https://openalex.org/W2044964190', 'https://openalex.org/W108756893'], 'abstract_inverted_index': {'Long-term': [0], 'administration': [1], 'of': [2, 51, 70, 113, 170, 182, 210, 230, 244], 'some': [3], 'antiepileptic': [4, 59, 207, 221], 'drugs': [5, 222], 'often': [6], 'increases': [7, 174], 'blood': [8, 211, 238], 'lipid': [9, 44, 76, 201, 234], 'levels.': [10, 213, 240], 'In': [11, 138, 156], 'this': [12, 245], 'study,': [13], 'we': [14], 'investigated': [15], 'its': [16], 'molecular': [17, 242], 'mechanism': [18, 243], 'by': [19, 86, 93, 220], 'focusing': [20], 'on': [21, 152], 'the': [22, 48, 54, 67, 153, 162, 180, 193, 206, 224], 'nuclear': [23, 251], 'receptors': [24, 252], 'constitutive': [25], 'active/androstane': [26, 217], 'receptor': [27, 32, 116, 218, 227, 257], '(CAR)': [28], 'and': [29, 43, 65, 126, 166, 179, 197, 236], 'peroxisome': [30, 114, 225, 255], 'proliferator–activated': [31, 115, 226, 256], '<i>α</i>': [33], '(PPAR<i>α</i>),': [34], 'which': [35], 'are': [36], 'key': [37], 'transcription': [38, 101, 229], 'factors': [39], 'for': [40, 123, 253], 'enzyme': [41], 'induction': [42], 'metabolism,': [45], 'respectively,': [46], 'in': [47, 80, 102, 107, 128, 135, 175], 'liver.': [49], 'Treatment': [50], 'mice': [52], 'with': [53, 95, 141], 'CAR': [55, 97, 125, 146, 160, 191], 'activator': [56], 'phenobarbital,': [57], 'an': [58], 'drug,': [60], 'increased': [61], 'plasma': [62, 176], 'triglyceride': [63, 177, 212, 239], 'levels': [64, 178], 'decreased': [66], 'hepatic': [68], 'expression': [69, 84], 'PPAR<i>α</i>': [71, 81, 89, 183, 196], 'target': [72, 82, 184], 'genes': [73, 231], 'related': [74, 232], 'to': [75, 233], 'metabolism.': [77, 202], 'The': [78, 110, 241], 'increase': [79], 'gene': [83, 100, 149, 185], 'induced': [85], 'fenofibrate,': [87], 'a': [88, 121], 'ligand,': [90], 'was': [91, 131], 'inhibited': [92], 'cotreatment': [94], 'phenobarbital.': [96], 'suppressed': [98, 147], 'PPAR<i>α</i>-dependent': [99, 148, 200], 'HepG2': [103, 136], 'cells': [104, 130, 143], 'but': [105], 'not': [106], 'COS-1': [108, 129, 142], 'cells.': [109, 137], 'mRNA': [111], 'level': [112], '<i>γ</i>': [117, 258], 'coactivator': [118, 122, 254], '1<i>α</i>': [119], '(PGC1<i>α</i>),': [120], 'both': [124], 'PPAR<i>α</i>,': [127], 'much': [132], 'lower': [133], 'than': [134], 'reporter': [139], 'assays': [140], 'overexpressing': [144], 'PGC1<i>α</i>,': [145, 198], 'transcription,': [150], 'depending': [151], 'coactivator-binding': [154], 'motif.': [155], 'mammalian': [157], 'two-hybrid': [158], 'assays,': [159], 'attenuated': [161], 'interaction': [163, 194], 'between': [164, 195, 249], 'PGC1<i>α</i>': [165, 171], 'PPAR<i>α</i>.': [167], 'Chemical': [168], 'inhibition': [169, 181, 246], 'prevented': [172], 'phenobarbital-dependent': [173], 'expression.': [186], 'These': [187], 'results': [188], 'suggest': [189], 'that': [190], 'inhibits': [192, 223], 'attenuating': [199], 'This': [203], 'might': [204], 'explain': [205], 'drug–induced': [208], 'elevation': [209], '<h3>SIGNIFICANCE': [214], 'STATEMENT</h3>': [215], 'Constitutive': [216], 'activated': [219], '<i>α</i>–dependent': [228], 'metabolism': [235], 'upregulates': [237], 'involves': [247], 'competition': [248], 'these': [250], 'coactivator-1<i>α</i>': [259], 'binding.': [260]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3083550746', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 3}, {'year': 2021, 'cited_by_count': 2}], 'updated_date': '2024-12-24T06:53:39.373447', 'created_date': '2020-09-11'}